Skip to main content
Figure 9 | BMC Biotechnology

Figure 9

From: Modifications of cysteine residues in the transmembrane and cytoplasmic domains of a recombinant hemagglutinin protein prevent cross-linked multimer formation and potency loss

Figure 9

A and B Pre-clinical mouse immunogenicity study results. Sera samples from mice immunized with the H3 A/Texas 5Cys SDV rHA antigen (B1-B3) and with the H3 A/Texas wild-type rHA antigen (A1-A3) were tested in the HAI assay using both antigens, the H3 A/Texas 5Cys rHA antigen (Panel A, left) and the H3 A/Texas wild-type rHA antigen (Panel B, right). In each plot, the dotted line represents 4× the mean value for the day 0 titer.

Back to article page

BMC Biotechnology

ISSN: 1472-6750

Contact us